MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $37,000 | +146.7% | 2,000 | -80.0% | 0.00% | +300.0% |
| Q3 2018 | $15,000 | -25.0% | 10,000 | -54.1% | 0.00% | -50.0% |
| Q1 2018 | $20,000 | -62.3% | 21,800 | +77.2% | 0.00% | 0.0% |
| Q4 2017 | $53,000 | -25.4% | 12,300 | +55.9% | 0.00% | -33.3% |
| Q3 2017 | $71,000 | -81.5% | 7,891 | -86.5% | 0.00% | -80.0% |
| Q2 2017 | $383,000 | +3730.0% | 58,405 | +6100.1% | 0.02% | – |
| Q1 2017 | $10,000 | -68.8% | 942 | -81.7% | 0.00% | -100.0% |
| Q4 2016 | $32,000 | -88.1% | 5,142 | -75.1% | 0.00% | -91.7% |
| Q3 2016 | $269,000 | +934.6% | 20,622 | +76.3% | 0.01% | +1100.0% |
| Q2 2016 | $26,000 | +1200.0% | 11,700 | +154.3% | 0.00% | – |
| Q1 2016 | $2,000 | -94.4% | 4,600 | -34.4% | 0.00% | -100.0% |
| Q4 2015 | $36,000 | – | 7,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 5,809,799 | $205,667,000 | 4.45% |
| Tieton Capital Management, LLC | 146,650 | $5,191,000 | 3.90% |
| KESTREL INVESTMENT MANAGEMENT CORP | 614,275 | $21,745,000 | 2.97% |
| Provident Investment Management, Inc. | 375,032 | $13,276,000 | 2.70% |
| Summit Street Capital Management, LLC | 77,810 | $2,754,000 | 2.46% |
| RATIONAL ADVISORS LLC | 253,200 | $8,963,000 | 2.17% |
| S&T BANK/PA | 393,446 | $13,928,000 | 2.08% |
| Euclidean Technologies Management, LLC | 63,684 | $2,254,000 | 2.05% |
| Grace Capital | 220,769 | $7,815,000 | 1.76% |
| AIMZ Investment Advisors, LLC | 57,850 | $2,048,000 | 1.75% |